[{"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "3880.00", "Date_of_Payment": "02/22/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "152477728", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Products, LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000325", "Total_Amount_of_Payment_USDollars": "3500.00", "Date_of_Payment": "11/02/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "267394504", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Zytiga", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Alexion Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005462", "Total_Amount_of_Payment_USDollars": "1500.00", "Date_of_Payment": "05/30/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "218586924", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLIRIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "1200.00", "Date_of_Payment": "06/27/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "189914298", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "931.00", "Date_of_Payment": "02/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477743", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "562.74", "Date_of_Payment": "05/02/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189915530", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Alexion Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005462", "Total_Amount_of_Payment_USDollars": "478.40", "Date_of_Payment": "05/29/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "218586920", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLIRIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Products, LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000325", "Total_Amount_of_Payment_USDollars": "320.11", "Date_of_Payment": "11/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "267394512", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Zytiga", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Alexion Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005462", "Total_Amount_of_Payment_USDollars": "313.60", "Date_of_Payment": "06/06/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "218586926", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLIRIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "301.40", "Date_of_Payment": "05/02/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189914280", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "281.96", "Date_of_Payment": "02/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477723", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Alexion Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005462", "Total_Amount_of_Payment_USDollars": "243.00", "Date_of_Payment": "05/30/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "218586922", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLIRIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Scientific Affairs, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000332", "Total_Amount_of_Payment_USDollars": "106.92", "Date_of_Payment": "09/24/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "23917021", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Zytiga", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "105.50", "Date_of_Payment": "05/02/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189913302", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "99.00", "Date_of_Payment": "11/30/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297667013", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "94.99", "Date_of_Payment": "11/20/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "111805338", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "85.00", "Date_of_Payment": "07/11/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168618808", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Products, LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000325", "Total_Amount_of_Payment_USDollars": "77.00", "Date_of_Payment": "08/22/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "17399956", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Zytiga", "Name_of_Associated_Covered_Drug_or_Biological2": "Doxil", "Contextual_Information": "Medical Textbook"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "59.99", "Date_of_Payment": "12/18/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "23817313", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Medical Textbook"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "59.46", "Date_of_Payment": "02/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477731", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Products, LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000325", "Total_Amount_of_Payment_USDollars": "50.00", "Date_of_Payment": "11/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "267394531", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Zytiga", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "37.92", "Date_of_Payment": "08/28/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "101791918", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "37.32", "Date_of_Payment": "02/22/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "152477735", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "36.16", "Date_of_Payment": "05/02/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189891166", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Products, LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000325", "Total_Amount_of_Payment_USDollars": "34.99", "Date_of_Payment": "11/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "267394518", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Zytiga", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "30.77", "Date_of_Payment": "12/28/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "332496123", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "OPDIVO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "25.77", "Date_of_Payment": "04/02/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156559212", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Zytiga", "Name_of_Associated_Covered_Drug_or_Biological2": "Imbruvica", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "23.63", "Date_of_Payment": "02/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297667010", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Prolia", "Name_of_Associated_Covered_Drug_or_Biological2": "XGEVA", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "22.72", "Date_of_Payment": "09/16/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189846720", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "Istodax", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "22.61", "Date_of_Payment": "02/18/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328343783", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "Pomalyst", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Grifols USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005420", "Total_Amount_of_Payment_USDollars": "22.60", "Date_of_Payment": "08/21/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "30680917", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Gamunex-C", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "22.17", "Date_of_Payment": "04/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328514178", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "Pomalyst", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "21.63", "Date_of_Payment": "09/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189853954", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "Pomalyst", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "21.13", "Date_of_Payment": "08/22/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "23870283", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Zytiga", "Name_of_Associated_Covered_Drug_or_Biological2": "Procrit", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "20.86", "Date_of_Payment": "12/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263310728", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MEKINIST", "Name_of_Associated_Covered_Drug_or_Biological2": "TAFINLAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "EISAI INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "20.79", "Date_of_Payment": "01/27/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "337968722", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ALOXI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "20.74", "Date_of_Payment": "08/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477766", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZYKADIA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "20.40", "Date_of_Payment": "05/06/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477754", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "20.40", "Date_of_Payment": "12/02/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477762", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZYKADIA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "20.39", "Date_of_Payment": "09/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328424780", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "Pomalyst", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "20.28", "Date_of_Payment": "10/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477710", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "19.30", "Date_of_Payment": "01/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263310754", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZYKADIA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "19.26", "Date_of_Payment": "05/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263310742", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "19.26", "Date_of_Payment": "02/05/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317906050", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "19.15", "Date_of_Payment": "02/26/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "221238380", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Eisai Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "19.07", "Date_of_Payment": "10/16/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "152501342", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Aloxi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "18.91", "Date_of_Payment": "12/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290172156", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "GILOTRIF", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "18.75", "Date_of_Payment": "11/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270224294", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZYTIGA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "18.48", "Date_of_Payment": "02/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "318075490", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Avastin", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "18.43", "Date_of_Payment": "01/07/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260069277", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FASLODEX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "18.23", "Date_of_Payment": "07/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328409384", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "Pomalyst", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "17.95", "Date_of_Payment": "01/16/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "187729822", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ERBITUX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "17.57", "Date_of_Payment": "01/29/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477748", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "EISAI INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "17.11", "Date_of_Payment": "04/21/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "338046988", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "HALAVEN", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "17.04", "Date_of_Payment": "10/06/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263310726", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "16.73", "Date_of_Payment": "10/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263310732", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TASIGNA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "16.66", "Date_of_Payment": "12/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477714", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "16.59", "Date_of_Payment": "08/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290172158", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "GILOTRIF", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "16.57", "Date_of_Payment": "04/15/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477752", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "16.57", "Date_of_Payment": "03/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189951536", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Alexion Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005462", "Total_Amount_of_Payment_USDollars": "16.30", "Date_of_Payment": "02/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "218577852", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLIRIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "16.28", "Date_of_Payment": "10/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270224286", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Imbruvica", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "16.21", "Date_of_Payment": "09/19/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "173284028", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "GRANIX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "16.12", "Date_of_Payment": "10/29/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "293839360", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TREANDA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Alexion Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005462", "Total_Amount_of_Payment_USDollars": "16.11", "Date_of_Payment": "10/25/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "103204422", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLIRIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "15.94", "Date_of_Payment": "05/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260086192", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FASLODEX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "15.82", "Date_of_Payment": "08/12/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "12099511", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FASLODEX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "15.79", "Date_of_Payment": "01/15/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "138171764", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Neulasta", "Name_of_Associated_Covered_Drug_or_Biological2": "NEUPOGEN", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Eisai Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "15.79", "Date_of_Payment": "11/06/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "184755308", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Halaven", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "15.69", "Date_of_Payment": "01/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328306288", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "Istodax", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "15.58", "Date_of_Payment": "12/19/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "14021037", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ERBITUX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Alexion Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005462", "Total_Amount_of_Payment_USDollars": "15.53", "Date_of_Payment": "08/26/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "338115074", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLIRIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "15.43", "Date_of_Payment": "11/20/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "12101004", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FASLODEX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "15.42", "Date_of_Payment": "06/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263310744", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MEKINIST", "Name_of_Associated_Covered_Drug_or_Biological2": "TAFINLAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "15.22", "Date_of_Payment": "02/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "138171766", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Neulasta", "Name_of_Associated_Covered_Drug_or_Biological2": "NEUPOGEN", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "15.22", "Date_of_Payment": "06/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "293839358", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TREANDA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Products, LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000325", "Total_Amount_of_Payment_USDollars": "14.99", "Date_of_Payment": "11/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "267394524", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Zytiga", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Products, LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000325", "Total_Amount_of_Payment_USDollars": "14.99", "Date_of_Payment": "11/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "267394538", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Zytiga", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "14.99", "Date_of_Payment": "03/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "293839356", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TREANDA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "14.73", "Date_of_Payment": "05/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317464570", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "14.65", "Date_of_Payment": "05/06/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331671583", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPRYCEL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "14.65", "Date_of_Payment": "08/31/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331923211", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "OPDIVO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "14.47", "Date_of_Payment": "11/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "138171768", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XGEVA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "EISAI INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "14.47", "Date_of_Payment": "11/20/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "337967090", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "HALAVEN", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "14.41", "Date_of_Payment": "02/19/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331543249", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPRYCEL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "14.35", "Date_of_Payment": "01/29/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "332315659", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "OPDIVO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "14.32", "Date_of_Payment": "02/11/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "319153847", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ELITEK", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Incyte Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000263", "Total_Amount_of_Payment_USDollars": "14.31", "Date_of_Payment": "01/15/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "298502858", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JAKAFI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Merck Sharp & Dohme Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000053", "Total_Amount_of_Payment_USDollars": "14.25", "Date_of_Payment": "05/30/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "201776450", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Non-Product", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Merck Sharp & Dohme Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000053", "Total_Amount_of_Payment_USDollars": "14.15", "Date_of_Payment": "02/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "330173735", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Non-Product", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Merck Sharp & Dohme Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000053", "Total_Amount_of_Payment_USDollars": "13.91", "Date_of_Payment": "10/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "202251860", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EMEND", "Name_of_Associated_Covered_Drug_or_Biological2": "SYLATRON", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "13.84", "Date_of_Payment": "06/16/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331690779", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPRYCEL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "13.82", "Date_of_Payment": "11/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "188839448", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JEVTANA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "13.67", "Date_of_Payment": "04/27/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339303764", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "13.38", "Date_of_Payment": "03/30/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290172160", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "GILOTRIF", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "13.35", "Date_of_Payment": "09/09/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156559214", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Zytiga", "Name_of_Associated_Covered_Drug_or_Biological2": "Imbruvica", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "13.24", "Date_of_Payment": "03/26/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297667006", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Neulasta", "Name_of_Associated_Covered_Drug_or_Biological2": "Vectibix", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "13.20", "Date_of_Payment": "03/06/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477786", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "13.07", "Date_of_Payment": "09/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263310738", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "13.07", "Date_of_Payment": "03/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317854032", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Avastin", "Name_of_Associated_Covered_Drug_or_Biological2": "Tarceva", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "12.97", "Date_of_Payment": "09/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "319837052", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JEVTANA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Bayer HealthCare Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005467", "Total_Amount_of_Payment_USDollars": "12.92", "Date_of_Payment": "12/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337914688", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xofigo", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "12.91", "Date_of_Payment": "04/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "318077106", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Avastin", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GENZYME CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000297", "Total_Amount_of_Payment_USDollars": "12.80", "Date_of_Payment": "10/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "188883446", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "CEREZYME", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "12.75", "Date_of_Payment": "06/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317854042", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Avastin", "Name_of_Associated_Covered_Drug_or_Biological2": "Tarceva", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "12.73", "Date_of_Payment": "09/08/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331960413", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ELIQUIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "LILLY USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "12.72", "Date_of_Payment": "09/19/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "4765410", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ALIMTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "12.59", "Date_of_Payment": "04/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260098228", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FASLODEX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Alexion Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005462", "Total_Amount_of_Payment_USDollars": "12.58", "Date_of_Payment": "08/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "218594602", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLIRIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Spectrum Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NV", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000011115", "Total_Amount_of_Payment_USDollars": "12.58", "Date_of_Payment": "11/16/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "340700204", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Folotyn", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "12.55", "Date_of_Payment": "08/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "294748258", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cresemba", "Name_of_Associated_Covered_Drug_or_Biological2": "Mycamine", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "12.48", "Date_of_Payment": "09/25/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275512522", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "12.48", "Date_of_Payment": "11/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263310730", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JADENU", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "12.40", "Date_of_Payment": "11/25/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "21837724", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TREANDA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Lilly USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "12.38", "Date_of_Payment": "12/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "268023822", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ERBITUX", "Name_of_Associated_Covered_Drug_or_Biological2": "CYRAMZA", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "12.23", "Date_of_Payment": "11/17/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "221251270", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Lilly USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "12.18", "Date_of_Payment": "05/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "268023818", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ALIMTA", "Name_of_Associated_Covered_Drug_or_Biological2": "CYRAMZA", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Incyte Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000263", "Total_Amount_of_Payment_USDollars": "12.04", "Date_of_Payment": "10/16/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "164165298", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JAKAFI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "12.01", "Date_of_Payment": "12/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "319798840", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JEVTANA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "11.95", "Date_of_Payment": "04/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263310746", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EXJADE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Bayer HealthCare Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005467", "Total_Amount_of_Payment_USDollars": "11.92", "Date_of_Payment": "06/30/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337903762", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Nexavar", "Name_of_Associated_Covered_Drug_or_Biological2": "Stivarga", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Incyte Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000263", "Total_Amount_of_Payment_USDollars": "11.91", "Date_of_Payment": "11/18/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "100005636", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JAKAFI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Eisai Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "11.78", "Date_of_Payment": "04/24/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "184763232", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Halaven", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "11.72", "Date_of_Payment": "05/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "188618372", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JEVTANA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "11.68", "Date_of_Payment": "03/23/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477703", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EXJADE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "11.67", "Date_of_Payment": "10/23/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "14269814", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZALTRAP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Emergent BioSolutions Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MD", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000011074", "Total_Amount_of_Payment_USDollars": "11.65", "Date_of_Payment": "09/05/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "31887318", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "11.64", "Date_of_Payment": "12/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "208283146", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Avastin", "Name_of_Associated_Covered_Drug_or_Biological2": "Tarceva", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "11.48", "Date_of_Payment": "09/11/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "21837723", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TREANDA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Merck Sharp & Dohme Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000053", "Total_Amount_of_Payment_USDollars": "11.34", "Date_of_Payment": "06/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "330637071", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Non-Product", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "11.29", "Date_of_Payment": "05/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477706", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EXJADE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "11.19", "Date_of_Payment": "05/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "319669620", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ELITEK", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Prometheus Laboratories Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010425", "Total_Amount_of_Payment_USDollars": "11.15", "Date_of_Payment": "10/10/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "219518880", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Proleukin", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "LILLY USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "11.14", "Date_of_Payment": "05/19/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "137724588", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "CYRAMZA", "Name_of_Associated_Covered_Drug_or_Biological2": "ALIMTA", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "11.11", "Date_of_Payment": "11/13/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "23817314", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Daiichi Sankyo Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000195", "Total_Amount_of_Payment_USDollars": "10.99", "Date_of_Payment": "04/30/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "326101766", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Savaysa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Daiichi Sankyo Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000195", "Total_Amount_of_Payment_USDollars": "10.98", "Date_of_Payment": "12/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "326275600", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Savaysa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Lilly USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "10.86", "Date_of_Payment": "08/26/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "268023820", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ALIMTA", "Name_of_Associated_Covered_Drug_or_Biological2": "CYRAMZA", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "10.85", "Date_of_Payment": "03/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295235740", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "LILLY USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "10.79", "Date_of_Payment": "02/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "137897988", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ALIMTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "10.71", "Date_of_Payment": "08/07/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "14257650", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JEVTANA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "10.69", "Date_of_Payment": "10/09/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "14021036", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ERBITUX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Incyte Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000263", "Total_Amount_of_Payment_USDollars": "10.66", "Date_of_Payment": "08/18/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "298502860", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Eisai Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "10.64", "Date_of_Payment": "02/11/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "184775590", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Halaven", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "10.64", "Date_of_Payment": "09/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477770", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "10.63", "Date_of_Payment": "08/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "188753866", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ELITEK", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "10.59", "Date_of_Payment": "12/16/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "8973578", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Nplate", "Name_of_Associated_Covered_Drug_or_Biological2": "Aranesp", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Merck Sharp & Dohme Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000053", "Total_Amount_of_Payment_USDollars": "10.50", "Date_of_Payment": "04/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "201522482", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Non-Product", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "10.46", "Date_of_Payment": "08/26/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477778", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "10.41", "Date_of_Payment": "10/29/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "8973579", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Neulasta", "Name_of_Associated_Covered_Drug_or_Biological2": "XGEVA", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Bayer HealthCare Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005467", "Total_Amount_of_Payment_USDollars": "10.37", "Date_of_Payment": "03/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337913302", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Nexavar", "Name_of_Associated_Covered_Drug_or_Biological2": "Stivarga", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "10.35", "Date_of_Payment": "12/11/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189877674", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Merck Sharp & Dohme Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000053", "Total_Amount_of_Payment_USDollars": "10.29", "Date_of_Payment": "02/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "201045914", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Non-Product", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "10.08", "Date_of_Payment": "12/02/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "332237705", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EMPLICITI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "10.03", "Date_of_Payment": "11/05/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "332125187", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ELIQUIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "10.02", "Date_of_Payment": "08/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477718", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "10.00", "Date_of_Payment": "02/22/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "152477739", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "9.95", "Date_of_Payment": "09/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263310736", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TASIGNA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "9.87", "Date_of_Payment": "01/27/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263310752", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TASIGNA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "9.38", "Date_of_Payment": "08/06/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297924386", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Luitpold Pharmaceuticals Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010540", "Total_Amount_of_Payment_USDollars": "9.26", "Date_of_Payment": "05/22/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "172031598", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Injectafer", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "9.20", "Date_of_Payment": "08/20/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "111793690", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "TARCEVA", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "8.70", "Date_of_Payment": "12/12/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "111750248", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "TARCEVA", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "8.68", "Date_of_Payment": "01/30/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168742172", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "Tarceva", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "8.62", "Date_of_Payment": "05/05/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263310748", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TASIGNA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "8.42", "Date_of_Payment": "05/27/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168867766", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Tarceva", "Name_of_Associated_Covered_Drug_or_Biological2": "Xtandi", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "8.22", "Date_of_Payment": "06/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263310740", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARYDAK", "Name_of_Associated_Covered_Drug_or_Biological2": "TASIGNA", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "7.94", "Date_of_Payment": "08/20/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "111810804", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "TARCEVA", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "7.83", "Date_of_Payment": "09/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168828526", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "7.80", "Date_of_Payment": "03/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477694", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "TASIGNA", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "7.79", "Date_of_Payment": "10/31/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "111737192", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "TARCEVA", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "7.70", "Date_of_Payment": "03/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263310750", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARYDAK", "Name_of_Associated_Covered_Drug_or_Biological2": "TASIGNA", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "7.64", "Date_of_Payment": "11/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477774", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "7.36", "Date_of_Payment": "08/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168864730", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "7.24", "Date_of_Payment": "07/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328424030", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "6.79", "Date_of_Payment": "03/25/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328339450", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "6.68", "Date_of_Payment": "07/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328390010", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "6.55", "Date_of_Payment": "10/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263310734", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "6.39", "Date_of_Payment": "10/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477758", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZYKADIA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "6.08", "Date_of_Payment": "11/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270224278", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "IMBRUVICA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "6.06", "Date_of_Payment": "08/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275512518", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XARELTO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Journal Article"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "6.06", "Date_of_Payment": "09/24/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275512520", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XARELTO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Journal Article"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "5.54", "Date_of_Payment": "09/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270224282", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Imbruvica", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "5.51", "Date_of_Payment": "04/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168524590", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Tarceva", "Name_of_Associated_Covered_Drug_or_Biological2": "Xtandi", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "4.78", "Date_of_Payment": "03/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189882388", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "4.41", "Date_of_Payment": "02/02/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331473093", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "4.24", "Date_of_Payment": "11/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270224274", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "IMBRUVICA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "3.70", "Date_of_Payment": "10/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270224290", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Imbruvica", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "3.57", "Date_of_Payment": "01/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477782", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "1.70", "Date_of_Payment": "03/25/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328339448", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "1.69", "Date_of_Payment": "02/19/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331543245", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPRYCEL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "LILLY USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "1.59", "Date_of_Payment": "09/18/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "4768761", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ALIMTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "1.43", "Date_of_Payment": "12/02/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "332237717", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EMPLICITI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "1.29", "Date_of_Payment": "11/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270224270", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "IMBRUVICA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "1.11", "Date_of_Payment": "05/06/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331671579", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPRYCEL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "1.00", "Date_of_Payment": "07/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328394532", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "0.99", "Date_of_Payment": "12/10/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189871560", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "0.68", "Date_of_Payment": "06/23/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152477700", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EXJADE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "0.57", "Date_of_Payment": "12/02/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "332237729", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EMPLICITI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "0.53", "Date_of_Payment": "02/19/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331543247", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPRYCEL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "257156", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "0.52", "Date_of_Payment": "08/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168735046", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}]